Brain stimulation, such as TMS, becomes standard depression treatment for many patients, offering new hope alongside medication management and counseling.
Hospital AI chatbots streamline pre-surgery prep by automating intake, flagging risks and guiding, cutting delays and cancellations, easing staff load.
Robotic exoskeletons boost stroke recovery by delivering high-intensity gait training with thousands of precise steps, surpassing traditional therapy limits.
Reviewing medications at home for safety with a medicines brown bag audit may help reduce errors and harm.
The FDA has approved the first gene therapy, Fayuvi, for Sanfilippo syndrome type A, offering hope to affected children.
The FDA's new pilot program aims to accelerate U.S. drug trials, reducing time from discovery to first-in-human studies.
AstraZeneca’s breast cancer drug Etcamah failed its first-line trial, SERENA-4, raising doubts about its potential as a frontline treatment for HR-positive pati
Novo Nordisk drops its full name to become 'Novo,' sharpening focus against Eli Lilly in weight loss and diabetes treatments amid slowing growth.
AbbVie’s Qulipta becomes first oral CGRP inhibitor to succeed in phase 3 menstrual migraine trials, offering hope for resistant cases.
Bayer secured FDA approval for Hyrnuo lung cancer treatment, marking a major shift in frontline HER2-mutant NSCLC care based on new clinical data.
© 2026 Vimeo Health. All rights reserved.
Theme by Auto UI Theme Builder.
